Measuring Early HIV Treatment Adherence
The study main objective is to “Examine Early HIV Treatment Adherence in different populations”. Specifically, looking on how people with high CD4 count (>350) adhere compared to people who have low CD4 count (<200) and how pregnant women adhere compared to non- pregnant women. Participants are monitored for 12 months using an electronic monitoring wireless adherence device (wisepill). META has two sites in Uganda; Mbarara and Kabwohe.
Principle Investigators: Dr. Jessica Harberer (MGH) and Dr. Bosco Bwana Mwebesa (MUST)